High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS
Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesic...
Үндсэн зохиолчид: | , , , , , , , , , , , , , |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Taylor & Francis Group
2021-09-01
|
Цуврал: | Human Vaccines & Immunotherapeutics |
Нөхцлүүд: | |
Онлайн хандалт: | http://dx.doi.org/10.1080/21645515.2021.1904758 |